Vinnie’s mom was overwhelmed.
Her cat had just been diagnosed with diabetes. The information felt like it had been dumped on her all at once. Insulin injections. Blood glucose monitoring. Dietary changes. Sharp needles. High costs.
Then we told her about a clinical trial.
Vinnie fit the demographics perfectly. Newly diagnosed. Otherwise healthy. And the investigational medication was oral, eliminating the need for those sharp needles his mom dreaded.
We didn’t know if Vinnie was getting the real medication or the placebo. That’s how blinded trials work. But Vinnie’s mom was convinced he had the real thing because of what she saw.
A pep in his step. His old eating habits returned. A big change in his litterbox frequency.
When the study ended, she tracked down the pharmaceutical sponsors and pleaded with them to release more medication. She couldn’t bear the thought of Vinnie losing his progress.
Luckily, Vinnie participated near the end of the trial. The FDA approved the medication shortly after, and it’s now in regular use for diabetic cats. The oral SGLT2 inhibitors proved over 80% effective in improving glycemic control.
Vinnie became a hero. A pioneer for other diabetic cats.
His face has graced veterinary conference presentations nationwide. His story gets told monthly at our clinic whenever we prescribe that life-changing medication. His owner sends us flowers on his birthday.
Why Cats Need Their Own Protocols
Here’s what most people don’t realize about veterinary clinical trials.
Cats aren’t small dogs.
They metabolize medications completely differently. Cats are deficient in glucuronidation enzymes, which means drugs that work perfectly fine in dogs can be toxic to cats. A single regular-strength acetaminophen tablet can kill a cat.
When pharmaceutical companies approach us with trial protocols, we get to push back. During protocol review, our feline experts weigh in on medication dosing, diagnostic procedures, and timelines.
Sometimes the entire study changes because of our input.
One trial wanted to start the investigational medication at a higher dose than we were comfortable administering. We didn’t care that it had been dosed that way in laboratory animals.
These aren’t laboratory animals. They’re family members who belong to valuable and conscientious clients.
Another trial wanted participants dropped off at the clinic. We know our patients are calmer and more relaxed when permitted to stay with their family. Cats want their people for comfort and trust.
Most dogs are happy to meet everybody. Cats are different.
When Research Meets Reality
We follow Good Clinical Practice standards. GCP guidelines ensure the quality, integrity, and safety of clinical research while protecting participant rights and well-being.
But we practice individualized care for all our patients. Even those enrolled in trials.
We’ve pulled patients from studies when the trial no longer serves them. Maybe an owner found administering the medication too cumbersome. Maybe a cat became too stressed with multiple veterinary visits.
Spanky was trialing a new blood pressure medication. Every time he came to his appointment, his blood pressure would spike dangerously high. We couldn’t collect accurate data from this nervous guy.
We released him from the trial for his own quality of life. He still received all his diagnostic work and a few kitty gifts for his limited participation.
The medication got FDA approval anyway. It’s helping hypertensive cats today. And Spanky’s stress response became valuable data about the medication’s limitations in anxious patients.
The Ripple Effect Nobody Talks About
Vinnie’s owner has made herself available to other newly diabetic cat owners who need support. She mentors them through the overwhelming early days.
That’s the part of clinical trials that doesn’t show up in research papers.
The studies we participate in address conditions many cat owners face themselves. Diabetes. Hypertension. Kidney disease. Arthritis. Heart disease. Cancer.
Many owners have had family members with these ailments. Previous pets with these conditions. They understand the bigger picture.
We discuss the greater good. How their cat fits into revolutionizing feline healthcare. How participation means free diagnostics, monthly check-ups, and medication. How they can stop anytime.
We gain their truly informed consent. They become partners in the study.
What We’re Still Missing
We’re proud to have helped bring new diabetic drugs, blood pressure medications, and arthritis treatments from Pharmaceutical Manufacturer Street to Main Street.
Our patients are living longer with better quality of life.
But cats are still suffering from conditions where we only have symptom management. Feline dental resorptive lesions. Glaucoma. Urinary crystals.
We have some medications and modalities to treat symptoms. Finding the cause and developing truly effective treatments remains the dream.
That’s why details matter so much in these trials. The slightest change in a patient’s condition is noteworthy. An owner’s offhanded observation can be crucial.
The FDA needs pristine paperwork to get life-changing medications on the market. To help the masses of cats who can’t wait to be healed.
Vinnie’s ears are still burning. His story continues to inspire overwhelmed cat owners facing new diagnoses.
And somewhere, another cat is about to become a pioneer.
